"none"@en . "9700526"^^ . "458270193"^^ . . "967"^^ . "Il lexatumumab o ETR2-ST01, \u00E8 un anticorpo monoclonale di tipo umano, che viene studiato per il trattamento di forme di tumore. Esso \u00E8 stato sviluppato dalla , Inc.. Il farmaco agisce sull'antigene: -R2."@it . "Lexatumumab (also known as ETR2-ST01) is an experimental agonistic human monoclonal antibody against TRAIL-R2 (DR5, APO-2), intended for the treatment of cancer. HGS-ETR2 antibodies were generated by Human Genome Sciences through a collaboration with Cambridge Antibody Technology. Development was discontinued in 2015."@en . . . . . "42"^^ . . "2002"^^ . . "\u0644\u0643\u0633\u0627\u062A\u0648\u0645\u0648\u0645\u0627\u0628 \u062C\u0633\u0645 \u0645\u0636\u0627\u062F \u0648\u062D\u064A\u062F \u0627\u0644\u0646\u0633\u064A\u0644\u0629 \u0628\u0634\u0631\u064A \u062A\u062C\u0631\u064A \u0639\u0644\u064A\u0647 \u0627\u0644\u062A\u062C\u0627\u0631\u0628 \u0627\u0644\u0633\u0631\u064A\u0631\u064A\u0629 \u0644\u0627\u0633\u062A\u062E\u062F\u0627\u0645\u0647 \u0641\u064A \u0639\u0644\u0627\u062C \u0627\u0644\u0633\u0631\u0637\u0627\u0646."@ar . . . . . . "Lexatumumab (also known as ETR2-ST01) is an experimental agonistic human monoclonal antibody against TRAIL-R2 (DR5, APO-2), intended for the treatment of cancer. HGS-ETR2 antibodies were generated by Human Genome Sciences through a collaboration with Cambridge Antibody Technology. Development was discontinued in 2015."@en . "changed"@en . . . "none"@en . . . . . "845816-02-6" . . . . . . . "TRAIL-R2"@en . . "Il lexatumumab o ETR2-ST01, \u00E8 un anticorpo monoclonale di tipo umano, che viene studiato per il trattamento di forme di tumore. Esso \u00E8 stato sviluppato dalla , Inc.. Il farmaco agisce sull'antigene: -R2."@it . "\u0644\u0643\u0633\u0627\u062A\u0648\u0645\u0648\u0645\u0627\u0628 \u062C\u0633\u0645 \u0645\u0636\u0627\u062F \u0648\u062D\u064A\u062F \u0627\u0644\u0646\u0633\u064A\u0644\u0629 \u0628\u0634\u0631\u064A \u062A\u062C\u0631\u064A \u0639\u0644\u064A\u0647 \u0627\u0644\u062A\u062C\u0627\u0631\u0628 \u0627\u0644\u0633\u0631\u064A\u0631\u064A\u0629 \u0644\u0627\u0633\u062A\u062E\u062F\u0627\u0645\u0647 \u0641\u064A \u0639\u0644\u0627\u062C \u0627\u0644\u0633\u0631\u0637\u0627\u0646."@ar . . . "967Q0SJD77" . . . "6346"^^ . . . "9832"^^ . . . . . "mab"@en . "u"@en . . "845816"^^ . . . . . . . . "Lexatumumab"@en . . . "1720"^^ . . "D06611" . . . "mab"@en . . "D06611"@en . . . "2767"^^ . "Lexatumumab"@it . "\u0644\u0643\u0633\u0627\u062A\u0648\u0645\u0648\u0645\u0627\u0628"@ar . "1058530797"^^ . . . . "changed"@en . .